Strasbaugh Announces Introduction of STB P300 CMP System at Semicon West

Strasbaugh (OTC Bulletin Board: STRB) announced today that its new STB P300 CMP system will be introduced at Semicon West in San Francisco, July 14-17, 2009.

The P300 is the semiconductor industry's first CMP system designed to incorporate Next Generation Factory principles. It combines the greatest production and process flexibility of any CMP machine on the market with the most advanced CMP technologies available. With industry-leading process performance, integrated state-of-the art wafer cleaning, low cost of ownership, and a capital cost of approximately 50% of the competition, the P300 offers device makers a new and better choice in CMP.

"The P300 is the first CMP machine in the industry designed to meet the demand for leaner, more agile, manufacturing," said Chuck Schillings, Strasbaugh Pres. & CEO. He added, "It provides improved process performance in a high production system that has the flexibility to support high mix, small lot applications -- all at a competitive capital cost. The P300 ushers in a new era in CMP process performance, manufacturability, and price." Strasbaugh's P300 is available in several configurations to best suit the unique needs of semiconductor, data storage, SOI, silicon, and MEMS manufacturing.

Several new CMP technologies will be introduced with the P300, including Strasbaugh's revolutionary new nVision II(TM) optical and motor current endpoint detection system, its new generation Saturn(TM) wafer carrier, the Precision(TM) pad conditioner, and industry-proven integrated cleaning.

Poted July 6th, 2009

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.